In fiscal year 2019, the share of revenue from U.S. drug formulations in relation to the total revenue was about 46 percent. During this year, the Indian pharmaceutical company launched 50 products in the U.S. and filed 63 abbreviated new drug applications.
Share of revenue of U.S. drug formulations of Aurobindo Pharma Limited to total revenue from financial year 2013 to 2019 (in billion Indian rupees)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Single Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- Aurobindo Pharma's revenue from ARV formulations FY 2013-2020
- Aurobindo Pharma's revenue from growth market formulations FY 2013-2020
- Aurobindo Pharma's expenditure on R&D FY 2017-2020, by type
- Aurobindo Pharma's revenue from U.S. formulations FY 2013-2020
- Aurobindo Pharma's EBITDA FY 2013-2020
- Aurobindo Pharma's revenue share 2020 by market
- Aurobindo Pharma's net debt to equity ratio FY 2013-2020
- Aurobindo Pharma's net debt to EBITDA ratio FY 2013-2020
- Aurobindo Pharma's EBITDA margin FY 2013-2020
- Aurobindo Pharma's ANDA filings 2019 by therapy
- Dr. Reddy's Laboratories' revenue FY 2014-2020
- Dr. Reddy's Laboratories' EBITDA FY 2014-2020
- Dr. Reddy's Laboratories' net worth FY 2014-2020
- Dr. Reddy's Laboratories' return on capital employed FY 2013-2020
- Dr. Reddy's Laboratories' revenue FY 2017-2020 by product segment
Aurobindo Pharma. (August 2, 2019). Share of revenue of U.S. drug formulations of Aurobindo Pharma Limited to total revenue from financial year 2013 to 2019 (in billion Indian rupees) [Graph]. In Statista. Retrieved March 07, 2021, from https://www.statista.com/statistics/996231/india-aurobindo-pharma-us-formulations-revenue-growth-share/
Aurobindo Pharma. "Share of revenue of U.S. drug formulations of Aurobindo Pharma Limited to total revenue from financial year 2013 to 2019 (in billion Indian rupees)." Chart. August 2, 2019. Statista. Accessed March 07, 2021. https://www.statista.com/statistics/996231/india-aurobindo-pharma-us-formulations-revenue-growth-share/
Aurobindo Pharma. (2019). Share of revenue of U.S. drug formulations of Aurobindo Pharma Limited to total revenue from financial year 2013 to 2019 (in billion Indian rupees). Statista. Statista Inc.. Accessed: March 07, 2021. https://www.statista.com/statistics/996231/india-aurobindo-pharma-us-formulations-revenue-growth-share/
Aurobindo Pharma. "Share of Revenue of U.S. Drug Formulations of Aurobindo Pharma Limited to Total Revenue from Financial Year 2013 to 2019 (in Billion Indian Rupees)." Statista, Statista Inc., 2 Aug 2019, https://www.statista.com/statistics/996231/india-aurobindo-pharma-us-formulations-revenue-growth-share/
Aurobindo Pharma, Share of revenue of U.S. drug formulations of Aurobindo Pharma Limited to total revenue from financial year 2013 to 2019 (in billion Indian rupees) Statista, https://www.statista.com/statistics/996231/india-aurobindo-pharma-us-formulations-revenue-growth-share/ (last visited March 07, 2021)